Stockreport

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings

Lumos Pharma, Inc.  (LUMO) 
PDF AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric G [Read more]